The Directorate General of Health Services (DGHS) has finalised the draft of a 137-page policy on corona vaccination in Bangladesh.
The draft was finalised today and has been sent to Health Ministry for approval, said Dr M Mushtuq Husain, member of National Deployment and Vaccination Plan for COVID-19 Vaccines in Bangladesh.
Earlier on Monday, the Oxford–AstraZeneca COVID-19 vaccine was approved for emergency use in Bangladesh by the Directorate General of Drug Administration (DGDA).
Major General Mohammad Mahbubur Rahman, Director General of the DGDA, gave temporary approval for use on an emergency basis.
Beximco has a deal with Serum Institute of India to import the Covid vaccine developed by Oxford University and AstraZeneca.
However, the deal apparently confronted a major setback on Sunday when the Indian authority had reportedly banned the commercial export of Oxford-AstraZeneca vaccine.
Even though ministers as well as top officials of Beximco came up optimistic and reassured that the reported ban will not affect the deal.
They said the Indian pharmaceutical company is bound to fulfill the agreement and Bangladesh will get the vaccine in due time.